OCUGEN, INC.
Profile
Company Names
OCUGEN, INC.
HISTOGENICS CORP
Addresses
5 GREAT VALLEY PARKWAY, SUITE 160, MALVERN, PA 19355
830 WINTER STREET, 3RD FLOOR, WALTHAM, MA 02451
830 WINTER STREET, WALTHAM, MA 02451
Phone Numbers
484-328-4698
(781) 547-7900
781-457-7900
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, OTHER HEALTH CARE
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$126,546,392.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2020-04-22
$14,283,724.00
$14,283,724.00
$0.00
Equity, Debt
4
2016-09-29
$30,000,001.00
$30,000,001.00
$0.00
Equity
3
2013-12-18
$10,323,988.00
$20,647,968.00
$10,323,980.00
Equity
2
2012-07-20
$37,638,679.00
$58,286,647.00
$20,647,968.00
Equity
1
2011-05-13
$34,300,000.00
INDEFINITE
INDEFINITE
Equity, Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN
CALLAHAN
EXECUTIVE OFFICER
PATRICK
FORTUNE
DIRECTOR
DAVID
GILL
DIRECTOR
CALYPSO MEDICAL TECHNOLOGIES INC
| CEMPRA, INC.
| ECPM HOLDINGS, LLC
| HISTOGENICS CORP
| MELINTA THERAPEUTICS, INC. /NEW/
| STRATA SKIN SCIENCES, INC.
| EVOLUS, INC.
| BIO2 TECHNOLOGIES, INC.
| PULSEON, INC.
| RAPIDPULSE, INC.
| MORPHOCEUTICALS, INC.
| PERIMETRICS, INC.
| 5 STAR RANCH, LLC
| BRIDGE TO LIFE LTD
PETER
GREENLEAF
EXECUTIVE OFFICER, DIRECTOR
ADAM
GRIDLEY
EXECUTIVE OFFICER, DIRECTOR
JOHN
JOHNSON
DIRECTOR
ALIGN FINANCIAL GROUP, INC.
| CEMPRA HOLDINGS, LLC
| NATIONAL PLANNING CORP/CA
| CEMPRA, INC.
| GLUE NETWORKS, INC.
| NATIONAL MOLDING LLC
| CATALYTIC HOLDINGS, LLC
| HISTOGENICS CORP
| HIGHLAND COPPER CO INC.
| SNAP INFUSION LLC
| CORTENDO AB
| MERCER SONOCO INVESTMENT FUND, A SERIES OF MERCER GROUP TRUST
| MERCER ACTIVE LONG CORPORATE INVESTMENT PORTFOLIO, A SERIES OF MERCER GROUP TRUST
| MERCER PHOENIX INVESTMENT PORTFOLIO, A SERIES OF MERCER GROUP TRUST
| MERCER BUYOUT-READY FUND, A SERIES OF MERCER GROUP TRUST
| MERCER OFFICEMAX CONSOLIDATED INVESTMENT PORTFOLIO, A SERIES OF MERCER GROUP TRUST
| MERCER OFFICEMAX SALARIED INVESTMENT PORTFOLIO, A SERIES OF MERCER GROUP TRUST
| MELINTA THERAPEUTICS, INC. /NEW/
| ROUNDPOINT MORTGAGE SERVICING CORP
| OPERATEMYBUILDING, INC.
| MIRATA PHARMACEUTICALS, LLC
| EVOLENT HEALTH, INC.
| HOSPITAL INNOVATIONS, LLC
| ENJOY EVERY SANDWICH LTD LIABILITY CO
| THEATRE OF THE UNIMPRESSED LTD LIABILITY CO
| ENJOY EVERY SARNIE LTD LIABILITY CO
| SECOND AVENUE JAMBOREE LTD LIABILITY CO
| STEREOPHONIC UK LTD LIABILITY CO
| SEVEN ROADS TOUR LTD LIABILITY CO
| FACE SPLIT OPEN LTD LIABILITY CO
| SHOW BIZ, ITS JUST SHOW BIZ LTD LIABILITY CO
| INTER ALIA BROADWAY LTD LIABILITY CO
GARHENG
KONG
DIRECTOR
CEMPRA HOLDINGS, LLC
| APPLIED GENETIC TECHNOLOGIES CORP
| VIAMET PHARMACEUTICALS INC
| ALDAGEN INC
| TRANSENTERIX INC
| CANCERGUIDE DIAGNOSTICS, INC.
| SARCODE BIOSCIENCE INC.
| SOFINNOVA VENTURE PARTNERS VIII, L.P.
| HISTOGENICS CORP
| CEMPRA, INC.
| ALIMERA SCIENCES INC
| FIRST AID BEVERAGES, INC.
| SOFINNOVA HEALTHQUEST PARTNERS, L.P.
| TRICE MEDICAL, INC.
| LONGWOOD OPPORTUNITY OFFSHORE FUND, LTD
| LONGWOOD OFFSHORE, LTD.
| CASTLE BIOSCIENCES INC
| STRONGBRIDGE BIOPHARMA PLC
| ACUTA OPPORTUNITY OFFSHORE FUND, LTD.
| ACUTA CAPITAL OFFSHORE FUND, LTD.
| HEALTHQUEST PARTNERS II, L.P.
| MAGNOLIA MEDICAL TECHNOLOGIES, INC.
| VENUS CONCEPT LTD.
| ALCRESTA THERAPEUTICS, INC.
| MELINTA THERAPEUTICS, INC. /NEW/
| AVEDRO INC
| CLEANSLATE CENTERS, INC.
| BARDY DIAGNOSTICS, INC.
| HEALTHQUEST PARTNERS III, L.P.
| HEALTHQUEST AJAX II SPV, L.P.
| AJAX HEALTH II LLC
| VENUS CONCEPT INC.
| HEALTHQUEST AJAX III SPV, L.P.
| AJAX HEALTH III LLC
| HEALTHQUEST AJAX III-A SPV, L.P.
| HEALTHQUEST MADISON SPV, L.P.
| HEALTHQUEST PARTNERS IV, L.P.
| HEALTHQUEST TACTICAL OPPORTUNITIES FUND, L.P.
| HOME HOSPITAL NEWCO, INC.
| HQTOF ENDEAVOR SPV, L.P.
| HQTOF ENDEAVOR SPV-B, L.P.
| NOMAD HEALTH, INC.
MICHAEL
LEWIS
DIRECTOR
ACTIVE IMPLANTS CORP
| AEOLUS PHARMACEUTICALS, INC.
| DAILY INCHES, INC.
| HISTOGENICS CORP
| BERENSON CAPITAL PARTNERS, LP
| INSIGHT GLOBAL, LLC
| POSY, LLC
| ONWARD CARE, INC.
| BYE UAS, INC.
| VELOCIS SECONDARY 2020-1, LP
| MYCROFT AI INC.
| EJOOV, INC.
| JABEZ BIOSCIENCES, INC.
| NOK THERAPEUTICS, INC.
JONATHAN
LIEBER
DIRECTOR
KEVIN
MCARDLE
EXECUTIVE OFFICER
SHANKAR
MUSUNURI
EXECUTIVE OFFICER, DIRECTOR
PATRICK
O-DONNELL
EXECUTIVE OFFICER, DIRECTOR
KEVIN
RAKIN
DIRECTOR
HELIX THERAPEUTICS, LLC
| HELIX THERAPEUTICS, INC.
| CYVEK, INC.
| HISTOGENICS CORP
| CHEETAH MEDICAL, INC.
| HIGHCAPE PARTNERS QP, L.P.
| HIGHCAPE PARTNERS, L.P.
| TELA BIO, INC.
| CYOMICS, LLC
| AZIYO BIOLOGICS, INC.
| CYBREXA HOLDING COMPANY, LLC
| CONVEXITY SCIENTIFIC INC.
| HIGHCAPE PARTNERS II, L.P.
| HIGHCAPE PARTNERS QP II, L.P.
| HIGHCAPE PARTNERS II QSI INVEST, L.P.
| ELUTIA PIPE INVESTMENT, LP
| ELUTIA INC.
| ALPHINA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity, Debt
2020-04-22
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-04-22
D
OTHER HEALTH CARE
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842]
DECLINE TO DISCLOSE
Equity
2016-09-29
